Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Triple-Hormone-Receptor Agonist Retatrutide for Obesity (PubMed abstract)
doi: 10.23736/S1973-9087.23.08025-5 36 MaggioM
Advances in experimental medicine and biology , 264 , 7984
Side Effect CJC-1295 + Ipamorelin HGH (Somatropin) Injection site reactions Common, mild Common, mild Water retention/edema Mild, transient Moderate to significant, dose-dependent Joint pain Rare Common at higher doses (carpal tunnel, arthralgia) Insulin resistance Not documented as significant Well-documented at supraphysiological doses Cortisol elevation Minimal (Ipamorelin is selective) Not directly caused by HGH Prolactin elevation Minimal (Ipamorelin advantage over GHRP-2/6) Not directly caused by HGH Organ enlargement risk Not documented (physiological GH levels) Documented at chronic supraphysiological doses Pituitary suppression Feedback loop preserved Natural GH production suppressed with prolonged use The side effect differential largely stems from the feedback loop distinction
